Efficacy and Safety of Tacrolimus versus Cyclosporine A for Idiopathic Membranous Nephropathy:A Network Meta-analysis / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
; (6): 41-51, 2018.
Article
ي En
| WPRIM
| ID: wpr-327729
المكتبة المسؤولة:
WPRO
ABSTRACT
Objective To compare the efficacy and safety of tacrolimus with those of cyclosporine in treating idiopathic membranous nephropathy (IMN) via network meta-analysis. Methods Databases including PubMed,Embase,CENTRAL (Cochrane),Wanfang Database,CNKI,and VIP citation database were searched for relevant studies according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Package Meta 4.5.0 and Gemtc 0.8.1 in R 3.3.1 were used to analyze the included studies. Results In this network meta-analysis,the complete remission rate (RR=0.98,95% CI0.70-1.40)and the total remission rate (RR=1.00,95% CI0.90-1.20)of idiopathic membranous nephropathy did not differ significantly between IMN patients treated with cyclosporine A or tacrolimusand,nor did the incidences of hepatic dysfunction(RR=1.40,95% CI0.52-4.00),infection(RR=0.75,95% CI0.18-3.10),or gastrointestinal syndrome(RR=2.1,95% CI0.36-28.00). Conclusion Cyclosporine A seems to have similar effectiveness and safety to tacrolimus in treating IMN.
النص الكامل:
1
الفهرس:
WPRIM
نوع الدراسة:
Systematic_reviews
اللغة:
En
مجلة:
Acta Academiae Medicinae Sinicae
السنة:
2018
نوع:
Article